Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Multivalent Human-Bovine Rotavirus Vaccine

  • Read more about Multivalent Human-Bovine Rotavirus Vaccine
Patent Cooperation Treaty
PCT/US1999/017036
Filed on 1999-07-27

BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS

  • Read more about BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS
US Application 09/307,987
Filed on 1999-05-10

Production Of Attenuated Respiratory Syncytial Virus Vaccines Involving Modification Of M2 ORF2

  • Read more about Production Of Attenuated Respiratory Syncytial Virus Vaccines Involving Modification Of M2 ORF2
US Application 60/143,097
Filed on 1999-07-09

HEPATITIS C VIRUS ENVELOPE PROTEIN MODIFIED FOR EXPRESSION ON THE HOST CELL SURFACE AND USE OF DNA CONSTRUCTS ENCODING THE MODIFIED PROTEIN

  • Read more about HEPATITIS C VIRUS ENVELOPE PROTEIN MODIFIED FOR EXPRESSION ON THE HOST CELL SURFACE AND USE OF DNA CONSTRUCTS ENCODING THE MODIFIED PROTEIN
Patent Cooperation Treaty
PCT/US1999/012665
Filed on 1999-06-04

T CELL RECEPTOR LIGANDS AND METHODS OF USING THE SAME

  • Read more about T CELL RECEPTOR LIGANDS AND METHODS OF USING THE SAME
US Application 09/293,738
Filed on 1999-04-16

3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES

  • Read more about 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES
US Application 09/269,367
Filed on 1999-03-23

Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B

  • Read more about Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B
Patent Cooperation Treaty
PCT/US1999/006225
Filed on 1999-03-22

METHODS OF TREATING ESTABLISHED COLITIS USING ANTIBODIES AGAINST IL-12

  • Read more about METHODS OF TREATING ESTABLISHED COLITIS USING ANTIBODIES AGAINST IL-12
Patent Cooperation Treaty
PCT/US1996/004337
Filed on 1996-03-29

TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS

  • Read more about TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS
US Patent 6,664,227
Filed on 1999-04-28

Method For Dectecing Antibodies To HAV 3C Proteinase

  • Read more about Method For Dectecing Antibodies To HAV 3C Proteinase
US Patent 6,156,499
Filed on 1998-09-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 551
  • Page 552
  • Page 553
  • Page 554
  • Page 555
  • Page 556
  • Page 557
  • Page 558
  • Page 559
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health